Important changes to the MRC Clinical Trials Unit at UCL
From April 2026, the MRC Clinical Trials Unit will become the UCL Innovative Clinical Trials Unit.
The MRC Clinical Trials Unit has received underpinning funding from the MRC since 1998. This has allowed the Unit to carry out innovative and challenging trials, meta-analyses and methodology research that have had a global impact. This funding will end in March 2026, due to changes in the MRC's funding approach. Preparing for this funding cut has been challenging. However, we will remain one of the largest clinical trials units in the UK and will maintain our wide portfolio of activity.
The MRC Clinical Trials Unit at UCL has always been defined by its dedication to impactful research, innovation, its culture of collaboration and mentorship, and its commitment to improving global health. The Innovative Clinical Trials Unit is committed to continuing to fulfil the mission of smarter studies and global impact, leading to better health. We will continue to successfully deliver new and ongoing studies, collaborating with partners around the world. The Innovative Clinical Trials Unit will be led by Professor Angela Meade, an experienced clinical trialist recognised for her strategic leadership and commitment to advancing collaborative research.
Professor Mahesh (Max) Parmar, the current Director of the MRC Clinical Trials Unit at UCL, will remain Director of the Institute of Clinical Trials and Methodology at UCL. Also, he is the Director of the new MRC funded Centre of Research Excellence in Clinical Trial Innovation, which opened in February 2026, supported by Professors James Carpenter, Ruth Langley and Ian White as Deputy Directors. The Innovative Clinical Trials Unit will capitalise on the existing close links and common staff with the Centre of Research Excellence in Clinical Trial Innovation to drive forward its mission.
The Innovative Clinical Trials Unit will remain part of the Institute of Clinical Trials and Methodology at UCL. Sponsorship of Unit studies will remain unchanged. Our new name, branding and web address will launch in April 2026.
Exciting Opportunity for future Medical Statisticians in sub Saharan Africa!
The London School of Hygiene and Tropical medicine and the International Statistics and Epidemiology Group are delighted to announce two funded scholarships for talented applicants from sub Saharan Africa with at least one year's experience of working in medical statistics or epidemiology.
What’s included:
๐ 1-year MSc in Medical Statistics at the London School of Hygiene & Tropical Medicine
๐ 1-year research placement with one of our partner institutions in Africa
๐๏ธ Applications close: 31 March
These scholarships form part of the MRC funded International Statistics and Epidemiology Partnership (ISEP), launched in January 2024. ISEP was created to tackle a long-standing shortage of highly trained medical statisticians at a time when health data and related research are expanding rapidly.
How to apply:
LMIC Mentoring Scheme - Now re-opened for Mentees and Mentors
The pilot of our new LMIC Mentoring Scheme has begun. The aim of the scheme is to link those working on clinical trials and studies in different organisations in LMIC (Low-and Middle-Income Countries) for online mentoring. The mentoring could be ...READ MORE
8 Essential Reading Lists now available
The Essential Reading Lists are a compilation of resources taken from the MRC Clinical Trials Unit at UCL Capacity Strengthening Hub Resources page. These resources have been collated into lists that we think will be useful for people working in ...READ MORE